Faculty of Health, Medicine and Life Sciences, School for Mental Health and Neuroscience, Alzheimer Centre Limburg, Maastricht University, UNS40 box 34, P.O. Box 616, 6200 MD, Maastricht, The Netherlands.
Faculty of Psychology and Neuroscience, Department of Cognitive Neuroscience, Maastricht University, Maastricht, The Netherlands.
Alzheimers Res Ther. 2021 Sep 24;13(1):159. doi: 10.1186/s13195-021-00902-8.
The brainstem locus coeruleus (LC) constitutes the intersection of the initial pathophysiological processes of Alzheimer's disease (AD) and sleep-wake dysregulation in the preclinical stages of the disease. However, the interplay between in vivo assessment of LC degeneration and AD-related sleep alterations remains unknown. Here, we sought to investigate whether MRI-assessed LC structural integrity relates to subjective sleep-wake measures in the context of AD plasma biomarkers, in cognitively unimpaired older individuals.
Seventy-two cognitively unimpaired older individuals aged 50-85 years (mean age = 65.2 ± 8.2 years, 37 women, 21 APOE ε4 carriers) underwent high-resolution imaging of the LC at 7 Tesla, and LC structural integrity was quantified using a data-driven approach. Reports on habitual sleep quality and nocturnal awakenings were collected using sleep questionnaires. Plasma levels of total tau, p-tau, Aβ, and Aβ were measured using single-molecule array technology.
Intensity-based cluster analyses indicated two distinct LC segments, with one covering the middle-to-caudal LC and displaying lower intensity compared to the middle-to-rostral cluster (t = -5.12, p < 0.0001). After correction for age, sex, depression, and APOE status, lower MRI signal intensity within the middle-to-caudal LC was associated with a higher number of self-reported nocturnal awakenings (F = 6.73, p = 0.03). Furthermore, this association was mostly evident in individuals with elevated levels of total tau in the plasma (F = 4.26, p = 0.04).
Our findings provide in vivo evidence that worse LC structural integrity is associated with more frequent nocturnal awakenings in the context of neurodegeneration, in cognitively unimpaired older individuals. These results support the critical role of the LC for sleep-wake regulation in the preclinical stages of AD and hold promises for the identification of at-risk populations for preventive interventions.
脑桥蓝斑(LC)是阿尔茨海默病(AD)初始病理生理过程和疾病临床前阶段睡眠-觉醒失调的交汇点。然而,活体评估 LC 退化与 AD 相关睡眠改变之间的相互作用尚不清楚。在这里,我们试图研究在认知未受损的老年人中,MRI 评估的 LC 结构完整性是否与 AD 血浆生物标志物背景下的主观睡眠-觉醒测量相关。
72 名认知未受损的 50-85 岁老年人(平均年龄=65.2±8.2 岁,37 名女性,21 名 APOE ε4 携带者)在 7 特斯拉进行 LC 高分辨率成像,并使用数据驱动方法量化 LC 结构完整性。使用睡眠问卷收集习惯性睡眠质量和夜间觉醒的报告。使用单分子阵列技术测量总 tau、p-tau、Aβ 和 Aβ 的血浆水平。
基于强度的聚类分析表明 LC 存在两个不同的节段,一个覆盖中至尾侧 LC,与中至头侧节段相比,其强度较低(t=-5.12,p<0.0001)。校正年龄、性别、抑郁和 APOE 状态后,中至尾侧 LC 内的 MRI 信号强度越低,自我报告的夜间觉醒次数越多(F=6.73,p=0.03)。此外,这种关联在血浆总 tau 水平升高的个体中更为明显(F=4.26,p=0.04)。
我们的研究结果提供了活体证据,表明在认知未受损的老年人中,LC 结构完整性越差,与神经退行性变背景下夜间觉醒次数越多相关。这些结果支持 LC 在 AD 临床前阶段对睡眠-觉醒调节的关键作用,并为识别有预防性干预风险的人群提供了希望。